My name is Jeffery Martin, and I am a second-year Master’s student working on the prostate cancer project in Dr. Porter’s lab in the Biomedical Science Department at the University of Windsor. In honour of Prostate Cancer Awareness Month, I would like to share some of the exciting prostate cancer research happening at the University […]
Groundbreaking Prostate Cancer Research at the University of Windsor Read More »
Christopher Jaworski Christopher Jaworski Glioblastoma (GBM) stands as one of the most lethal and aggressive brain cancers, often defying current treatment strategies. The outlook for patients remains grim, with average survival hovering around just 14 months after diagnosis. A major reason for this is the tumor’s ability to resist therapy and recur, often driven by
Stephanie Dinescu Glioblastoma (GBM) is the most frequent and aggressive primary malignant brain tumour. Despite rigorous therapeutic efforts, the prognosis of GBM remains extremely low, with a median survival of approximately 14 months after diagnosis. Our lab studies a cyclin-like protein called Spy1 which has been found to be elevated in GBM. Spy1 overrides cell-cycle checkpoints
Amy Llancari My project focuses on differentiating the progression of Non-alcoholic Fatty Liver Disease (NALFD) into Hepatocellular Carcinoma (HCC) between male and female mice. HCC is the sixth most prevalent cancer in the world, yet it ranks as the third leading type of cancer deaths with an accelerated increase in incidence rates. NAFLD is a
Tiana Visconti Determining the Dependency of Spy1 based on Rb Status in Triple Negative Breast Cancer Breast cancer is the second most common cancer worldwide and the most common cancer among women. Triple Negative Breast Cancer (TNBC) is a particularly aggressive form of breast cancer with many subtypes based on gene expression profiles. There
Undergrads 2022 – part 3 Read More »
Ali Nadi Applying CRISPR/Cas9 and Fluorescent Tools to Dissect the Role of Tuberin in Cell Cycle Regulation How cells regulate their growth and division involves a tightly controlled integration of many mechanisms. In cells, Tuberin (gene – TSC2) is a protein in the Tuberous Sclerosis Complex (TSC) which modulates cellular growth, size, and proliferation. Mutations in
Undergrads 2022 – part 2 Read More »
During our lab meeting today one of our graduate students, Isabelle Hinch, presented a great seminar about Mental Health in Academia. Academic life, for both faculty and students, has always been stressful, but the pandemic has made it worse. In her presentation, Isabelle share resources that can help to deal with the insecurities and stress
Mental Health in Academia Read More »
Two of our awesome undergraduate students are sharing their projects and experiences during their time in our lab. Check here to read the first post about our 2021 undergraduate students. Evaluation of the cell cycle regulation in Tuberin knockout cell lines Tuberin (TSC2) and its binding partner hamartin (TSC1) are tumour suppressor proteins that regulate
2021 Undergraduate Theses – Antonio and Jared Read More »
Our 2021 undergraduate students have done wonderful work presenting their research results at the Ontario Biology Day, UWill Discover, and our Undergraduate Research Colloquium. Our lab has faced many challenges during this past year, the pandemic has tested our limits in many ways, but we are keeping up with our outstanding research projects. We had
2021 Undergraduate Theses – Kate, Kim, and Sami Read More »
No position is available at the moment.
For interested graduate students please visit the University of Windsor Department of Biology for admission requirements (http://www1.uwindsor.ca/biology/graduate-program) and contact Dr Bre-Anne Fifield (fifield@uwindsor.ca) to express your interest in joining the lab.
For volunteers please contact Dr Dorota Lubanska (lubanskd@uwindsor.ca) and indicate the year you are in and the type of experience you are interested in. Note that interviews only happen once a year in the Spring.
Please click on the link below:
http://windsorcancerresearch.com/research/application-of-interest-in-cancer-research/